Institutional members access full text with Ovid®

Share this article on:

Gamma-aminobutyric acid A receptor, α-2 (GABRA2) variants as individual markers for alcoholism: a meta-analysis

Zintzaras, Eliasa,b

doi: 10.1097/YPG.0b013e328353ae53
Original Articles

Objectives The available evidence from the genetic association studies (GAS) published to date on the association between variants in the GABRA2 gene and alcoholism has produced inconclusive results. To interpret these results, a meticulous meta-analysis of all available studies was carried out.

Methods The PubMed database and the HuGE Navigator were searched for published GAS-related variants in the GABRA2 gene with susceptibility to alcoholism. Then, the GAS were synthesized to decrease the uncertainty of estimated genetic risk effects. The risk effects were estimated on the basis of the odds ratio (OR) of the allele contrast and the generalized odds ratio (ORG), a model-free approach. Cumulative and recursive cumulative meta-analyses (CMA) were also carried out to investigate the trend and stability of effect sizes as evidence accumulates.

Results Fourteen variants investigated in eight studies were analyzed. Significant associations were derived for four variants either for the allele contrast or for the ORG. In particular, the variants rs279858 and rs279845 showed marginal significance for ORG: ORG=1.27 (1.01–1.60) and ORG=1.49 (1.02–2.19), respectively. Also, the variants rs567926 and rs279844 showed significance for the allele contrast: OR=1.24 (1.06–1.46) and OR=1.23 (1.08–1.43), respectively; the ORG produced similar results. The variant rs279858 produced a large heterogeneity between studies. CMA showed a trend of an association only for the variant rs567926. Recursive CMA indicated that more evidence is needed to conclude on the status of significance of all variants.

Conclusion There is evidence that variants in the GABRA2 gene are associated with alcoholism. However, the present findings should be interpreted with caution.

aDepartment of Biomathematics, University of Thessaly School of Medicine, Larissa, Greece

bThe Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA

Correspondence to Elias Zintzaras, PhD, Department of Biomathematics, University of Thessaly School of Medicine, 2 Panepistimiou Str, Larissa 41110, Greece Tel: +30 241 056 5270; fax: +30 241 056 5270; e-mail:

Received May 25, 2011

Accepted November 28, 2011

© 2012 Lippincott Williams & Wilkins, Inc.